Company Analysis JW (Cayman) Therapeutics Co. Ltd
1. Summary
Advantages
- Price (0.4523 $) is less than fair price (0.5173 $)
- The stock's return over the last year (77.37%) is higher than the sector average (-38.78%).
Disadvantages
- Dividends (0%) are below the sector average (1.7%).
- Current debt level 25.17% has increased over 5 years from 9.11%.
- The company's current efficiency (ROE=-297.29%) is lower than the sector average (ROE=14.54%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| JW (Cayman) Therapeutics Co. Ltd | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 1.3% | -0.6% |
| 90 days | 80.9% | -40.7% | 3.1% |
| 1 year | 77.4% | -38.8% | 12% |
JWCTF vs Sector: JW (Cayman) Therapeutics Co. Ltd has outperformed the "Healthcare" sector by 116.16% over the past year.
JWCTF vs Market: JW (Cayman) Therapeutics Co. Ltd has outperformed the market by 65.37% over the past year.
Slightly volatile price: JWCTF is more volatile than the rest of the market on "OTC" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: JWCTF with weekly volatility of 1.49% over the past year.
3. Summary of the report
5. Fundamental Analysis
5.1. Stock price and price forecast
Below fair price: The current price (0.4523 $) is lower than the fair price (0.5173 $).
Price not significantly lower than the fair price: The current price (0.4523 $) is slightly lower than the fair price by 14.4%.
5.2. P/E
P/E vs Sector: The company's P/E (-0.4629) is lower than that of the sector as a whole (46.22).
P/E vs Market: The company's P/E (-0.4629) is lower than that of the market as a whole (45.44).
5.3. P/BV
P/BV vs Sector: The company's P/BV (0.4184) is lower than that of the sector as a whole (5.41).
P/BV vs Market: The company's P/BV (0.4184) is lower than that of the market as a whole (4.4).
5.3.1 P/BV Similar companies
5.5. P/S
P/S vs Sector: The company's P/S indicator (0.4235) is lower than that of the sector as a whole (4.38).
P/S vs Market: The company's P/S indicator (0.4235) is lower than that of the market as a whole (13.03).
5.5.1 P/S Similar companies
5.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-0.0432) is lower than that of the sector as a whole (17.44).
EV/Ebitda vs Market: The company's EV/Ebitda (-0.0432) is lower than that of the market as a whole (24.02).
6. Profitability
6.1. Profitability and revenue
6.2. Earnings per share - EPS
6.3. Past profitability Net Income
Yield Trend: Rising and has grown by 31.21% over the last 5 years.
Earnings Slowdown: The last year's return (0.7092%) is below the 5-year average return (31.21%).
Profitability vs Sector: The return for the last year (0.7092%) exceeds the return for the sector (-1.62%).
6.4. ROE
ROE vs Sector: The company's ROE (-297.29%) is lower than that of the sector as a whole (14.54%).
ROE vs Market: The company's ROE (-297.29%) is lower than that of the market as a whole (51.15%).
6.6. ROA
ROA vs Sector: The company's ROA (-221.84%) is lower than that of the sector as a whole (7.4%).
ROA vs Market: The company's ROA (-221.84%) is lower than that of the market as a whole (36.09%).
6.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (14.06%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (10.88%).
8. Dividends
8.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.7%.
8.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
8.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
Based on sources: porti.ru
